195 related articles for article (PubMed ID: 32661772)
1. NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists.
Srivastava RAK; Cefalu AB; Srivastava NS; Averna M
Mol Cell Biochem; 2020 Oct; 473(1-2):247-262. PubMed ID: 32661772
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8.
Calpe-Berdiel L; Rotllan N; Fiévet C; Roig R; Blanco-Vaca F; Escolà-Gil JC
J Lipid Res; 2008 Sep; 49(9):1904-11. PubMed ID: 18509196
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8.
Yu L; York J; von Bergmann K; Lutjohann D; Cohen JC; Hobbs HH
J Biol Chem; 2003 May; 278(18):15565-70. PubMed ID: 12601003
[TBL] [Abstract][Full Text] [Related]
4. Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis.
Srivastava N; Cefalu AB; Averna M; Srivastava RAK
Front Physiol; 2018; 9():1222. PubMed ID: 30271349
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the expression of cholesterol transporters by lipid-lowering drugs ezetimibe and pemafibrate in rat liver and intestine.
Tanaka Y; Kamisako T
Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166215. PubMed ID: 34265370
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
[TBL] [Abstract][Full Text] [Related]
7. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G
Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
[TBL] [Abstract][Full Text] [Related]
8. Metformin and AMP Kinase Activation Increase Expression of the Sterol Transporters ABCG5/8 (ATP-Binding Cassette Transporter G5/G8) With Potential Antiatherogenic Consequences.
Molusky MM; Hsieh J; Lee SX; Ramakrishnan R; Tascau L; Haeusler RA; Accili D; Tall AR
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1493-1503. PubMed ID: 29853564
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of anti-atherosclerotic activities of PPAR-α, PPAR-γ, and LXR agonists in hyperlipidemic atherosclerosis-susceptible F(1)B hamsters.
Srivastava RA
Atherosclerosis; 2011 Jan; 214(1):86-93. PubMed ID: 21093860
[TBL] [Abstract][Full Text] [Related]
10. Diosgenin stimulation of fecal cholesterol excretion in mice is not NPC1L1 dependent.
Temel RE; Brown JM; Ma Y; Tang W; Rudel LL; Ioannou YA; Davies JP; Yu L
J Lipid Res; 2009 May; 50(5):915-23. PubMed ID: 19141868
[TBL] [Abstract][Full Text] [Related]
11. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice.
Nijstad N; Gautier T; Briand F; Rader DJ; Tietge UJ
Gastroenterology; 2011 Mar; 140(3):1043-51. PubMed ID: 21134376
[TBL] [Abstract][Full Text] [Related]
12. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1.
Plōsch T; Kok T; Bloks VW; Smit MJ; Havinga R; Chimini G; Groen AK; Kuipers F
J Biol Chem; 2002 Sep; 277(37):33870-7. PubMed ID: 12105210
[TBL] [Abstract][Full Text] [Related]
13. Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice.
Wang HH; Li X; Patel SB; Wang DQ
Hepatology; 2016 Sep; 64(3):853-64. PubMed ID: 27014967
[TBL] [Abstract][Full Text] [Related]
14. Induction of fecal cholesterol excretion is not effective for the treatment of hyperbilirubinemia in Gunn rats.
Blankestijn M; van de Peppel IP; Dvorak A; Capkova N; Vitek L; Jonker JW; Verkade HJ
Pediatr Res; 2021 Feb; 89(3):510-517. PubMed ID: 32357361
[TBL] [Abstract][Full Text] [Related]
15. Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice.
Groen A; Kunne C; Jongsma G; van den Oever K; Mok KS; Petruzzelli M; Vrins CL; Bull L; Paulusma CC; Oude Elferink RP
Gastroenterology; 2008 Jun; 134(7):2091-100. PubMed ID: 18466903
[TBL] [Abstract][Full Text] [Related]
16. Genetic inactivation of NPC1L1 protects against sitosterolemia in mice lacking ABCG5/ABCG8.
Tang W; Ma Y; Jia L; Ioannou YA; Davies JP; Yu L
J Lipid Res; 2009 Feb; 50(2):293-300. PubMed ID: 18796403
[TBL] [Abstract][Full Text] [Related]
17. Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing
Kikuchi T; Orihara K; Oikawa F; Han SI; Kuba M; Okuda K; Satoh A; Osaki Y; Takeuchi Y; Aita Y; Matsuzaka T; Iwasaki H; Yatoh S; Sekiya M; Yahagi N; Suzuki H; Sone H; Nakagawa Y; Yamada N; Shimano H
Mol Metab; 2016 Nov; 5(11):1092-1102. PubMed ID: 27818935
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
Breevoort SR; Angdisen J; Schulman IG
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
[TBL] [Abstract][Full Text] [Related]
19. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR.
Khovidhunkit W; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
J Lipid Res; 2003 Sep; 44(9):1728-36. PubMed ID: 12777468
[TBL] [Abstract][Full Text] [Related]
20. Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice.
Wang J; Einarsson C; Murphy C; Parini P; Björkhem I; Gåfvels M; Eggertsen G
J Lipid Res; 2006 Feb; 47(2):421-30. PubMed ID: 16264196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]